Percentage Venous Options in Pediatrics & Adults

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-06-30

Study Completion Date

2011-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

VeinViewer® Vision will significantly increase the number of peripheral intravenous catheter access targets perceived by clinicians with experience in intravenous cannulation when compared to the number of access targets that these clinicians are able to visualize unaided or to palpate.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Veins

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Veins Catheter Segments Vascular Access VeinViewer Vision

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 17 years of age or younger,
* Intact skin, without rash,irritation, scarring, open abrasion or other injury in these sites.
* Parent or guardian is English speaking
* Pediatric patients 8 years older will be asked to provide assent
* Participant does not have an acute or critical medical illness or injury requiring immediate evaluation and/or treatment.

* Age 18 years or older,
* At least one intact upper extremity (intact from the base knuckle to the shoulder)
* Intact skin on the dorsum of the hand, the ventral forearm, and antecubital fossa, without rash, irritation, scarring, open abrasion or other injury in these sites.
* Participant does not have an acute or critical medical illness or injury requiring immediate evaluation and/or treatment.

Exclusion Criteria

* 18 years of age or older
* No intact upper extremities
* Patient has had current or recent (within 6 months) venous access in the arm that will be evaluated.
* Acute or critical illness or injury requiring immediate or urgent evaluation and treatment.

Adult arm:

* Younger than 18 years of age
* No intact upper extremities
* The participant does not have intact skin on the dorsum of the hand, the ventral forearm, and antecubital fossa, without rash, irritation, scarring, open abrasion or other injury preventing appropriate evaluation of these sites.
* Non-English speaking participant.
* Patient has had current or recent (within 6 months) venous access in the arm that will be evaluated.
* Acute or critical illness or injury requiring immediate or urgent evaluation and treatment.

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bruce M Becker, MD

Role: PRINCIPAL_INVESTIGATOR

Hasbro Children's Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

HASBRO Children's Hospital

Providence, Rhode Island, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CP1001

Identifier Type: -

Identifier Source: org_study_id